Osteoarthritis Shoulder Clinical Trial
Official title:
Endogenous Pain Modulation in Patients With Shoulder Arthroplasty for Osteoarthritis
Rationale: Although most patients experience significant pain relief after total shoulder arthroplasty (TSA), pain persists for some patients even after surgery. The endogenous pain system may be involved in persisting postoperative pain in total knee arthroplasty (TKA) and total hip arthroplasty (THA) patients, but this has never been studies for TSA patients. Furthermore, psychological factors and coping strategies may also be of interest but have not yet been extensively studied in TSA patients. Objective: The primary objective is to explore whether central sensitization and/or abnormal CPM responses are present in (a subgroup of) patients who will receive shoulder arthroplasty for osteoarthritis, and whether shoulder arthroplasty produces change in these measures of the endogenous pain modulatory system. The secondary objective, in case patients with altered endogenous pain modulation are found, is to explore if change in pain over time, psychological factors and coping strategies differ between patients with and without altered pain modulation. Study design: An exploratory prospective observational cohort study. Study population: Patients (age 18 years or older) who are scheduled to undergo shoulder arthroplasty for osteoarthritis, at the Reinier Haga Orthopaedic Centre. Intervention (if applicable): Not applicable. Main study parameters/endpoints: The main study parameters are CPM and TS values at baseline and at 3 and 6 months after surgery, as well as the absence/presence of allodynia at baseline and at 3 and 6 months after surgery. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The burden of participation will consist of completing questionnaires at baseline and at three and six months after surgery. In addition, subjects will undergo psychophysical testing at 3 moments, which can lead to redness or a burning sensation of the skin during the first 24 hours after testing. The investigators do not expect any additional risks associated with participation. There is no direct benefit for the subjects.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
| Not yet recruiting |
NCT04448106 -
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
|
Phase 2 | |
| Enrolling by invitation |
NCT05067543 -
Perform Humeral System Study
|
||
| Completed |
NCT04641546 -
Effectiveness of Occupation-Based Intervention Compared With Therapeutic Exercise for Older Adults With Shoulder OA.
|
N/A | |
| Recruiting |
NCT05868148 -
Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study
|
||
| Completed |
NCT03431857 -
Multi Centre Study on TESS V2 Shoulder System
|
||
| Recruiting |
NCT06078865 -
FX Shoulder Prospective Clinical Study
|
||
| Recruiting |
NCT04929951 -
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
|
Phase 1 | |
| Recruiting |
NCT04968405 -
Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
|
N/A | |
| Enrolling by invitation |
NCT05500066 -
AEQUALIS™ FLEX REVIVE™ Study (REVIVE)
|
||
| Recruiting |
NCT05002959 -
TESS V3 Modular Total Shoulder System PMCF
|
||
| Recruiting |
NCT06077942 -
FX Shoulder Solutions Retrospective / Prospective Clinical Study
|
||
| Active, not recruiting |
NCT06171542 -
Efficacy of a Single Image Guided Injection of CTM for Glenohumeral Arthritis
|
Phase 1 | |
| Recruiting |
NCT05487274 -
TSA v RSA in Osteoarthritic Shoulders With Greater Than 15 Degrees of Retroversion
|
N/A | |
| Not yet recruiting |
NCT06032416 -
DenCT Shoulder Bone Quality Evaluation
|
N/A |